OrthoPediatrics Corp. announced the 510(k) approval, and limited U.S. launch of its first sterile-packed implants for the Pediatric Nailing Platform | FEMUR (“PNP|FEMUR”). The PNP|FEMUR system, now available in 4 countries, was designed for use in pediatric patients to address femoral shaft fractures, subtrochanteric femur fractures, ipsilateral neck/shaft fractures, prophylactic nailing of impending pathologic fractures, nonunions, malunions, and fixation of femurs that have been surgically prepared (osteotomy) for correction of deformity. Worldwide, the PNP|FEMUR system has been used to treat over 1,000 children since its launch in 2018. With the introduction of sterile nails, the next generation PNP|FEMUR system continues to add more options and new flexibility for surgeons and hospital systems. Now, the most comprehensive pediatric specific PNP|FEMUR implant offering will be made available sterile. The 510(k) clearance and availability of this implant helps hospitals improve patient safety and better trace implant usage while lowering Sterile Processing Departments’ turnover burden and costs.